Meet Dr. Nancy E. Davidson
Nancy E. Davidson, MD
Dr. Nancy E. Davidson, nationally renowned authority on breast cancer and Director of the University of Pittsburgh Cancer Institute (UPCI) and UPMC Cancer Centers, visited Erie and The RCC for the first time on May 10.
The power of academic medical centers joining forces with community hospitals is quickly becoming a trend in cancer care – and it’s a trend RCC, UPMC Cancer Centers, and Hamot and Saint Vincent hospitals recognized early. As the lead physician of our affiliation partner and NCI-designated comprehensive cancer center, Dr. Davidson’s visit creates a forum for exchanging thoughts, perspectives, and priorities for the future of cancer care at RCC including ideas about ongoing clinical opportunities of the affiliation.
One of the benefits of the RCC’s association with UPCI and UPMC Cancer centers is access to a wide variety of clinical trials. Research is one of the most effective tools in developing new and improved cancer treatment protocols. Many of the most effective cancer treatments available today, from the latest surgical techniques to radiation therapies to the wide variety of drug therapies, have evolved from work begun in research laboratories. Through relationships with community cancer centers like RCC, UPMC and UPCI have an opportunity to bring leading edge research trials to the community setting, providing local patients with novel treatment options close to home.
Dr. Davidson, Dr. Wynn, and John Girard
Nancy E. Davidson, MD, is nationally renowned for her research involving breast cancer. Prior to joining UPCI and UPMC Cancer Centers she served as director of the Johns Hopkins Kimmel Cancer Center’s Breast Cancer Program in Baltimore and as professor of oncology at Johns Hopkins School of Medicine.
Dr. Davidson has published key findings on the role of hormones, particularly estrogen, on gene expression and cell growth in breast cancer, and guided several important national clinical trials of potential new therapies, including the use of chemoendocrine therapy premenopausal breast cancer and antiangiogenesis therapy for advanced disease.
She recently served as president of the American Society of Clinical Oncology (ASCO), is a member of the scientific advisory board of numerous foundations, and the recipient of numerous awards, including the Brinker International Award for Breast Cancer Research.
In February 2009 she assumed leadership as director of UPCI and UPMC Cancer Centers; Professor of Medicine and Pharmacology and Chemical Biology; Associate Vice Chancellor for Cancer Research; Hillman Professor of Oncology; and chief of the Division of Hematology/Oncology at the University of Pittsburgh School of Medicine.
2500 West 12th St.